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In this issue of Immunity, Devadas and colleagues
(2006) reveal that granzyme B, long known as a media-
tor of CD8+ T cell cytotoxicity, has a new role in an in-
ternal homeostatic death mechanism that controls the
fate of CD4+ T helper 2 cells.
Soon after it was recognized that T lymphocytes have cy-
totoxic, i.e., cell killing, activity, two forms of cytoxicity
were distinguished by whether or not they required cal-
cium (Ka¨gi et al., 1996). The calcium-dependent mecha-
nism involves the release of granules containing perforin
and death-inducing serine proteases called granzymes.
Calcium-independent death occurs by a completely dif-
ferent mechanism involving an inducible cell-surface
protein, called Fas ligand, that is related to tumor necro-
sis factor (TNF) and specifically binds the Fas receptor
(also known as CD95 or APO-1). Thus, there are two dis-
tinct killing mechanisms, and both mechanisms play
a crucial role in immunity by enabling CD8+ cytolytic
T cells or natural killer (NK) cells to destroy virally infected
or tumorigenic target cells. These cytolytic mechanisms
may also be involved in damaging effects of T cell re-
sponses such as in autoimmune disease and graft
rejection (Ka¨gi et al., 1996).
However, cell death has another vital role in immunity.
T lymphocyte numbers and activity are regulated
throughout the course of immune responses. After
antigenic stimulation, T cells have a burst of prolifera-
tion, which greatly increases the number of specific
effector cells to facilitate a strong protective immune re-
sponse. However, cell numbers must be tightly con-
trolled to avoid the negative consequences of vast num-
bers of activated T cells, such as autoimmune reactions.
Therefore, T lymphocytes have evolved means to down-
regulate their own numbers by propriocidal or ‘‘self-kill-
ing’’ mechanisms that appear to be hard-wired into the
biology of these cells (Lenardo et al., 1999). Soon after
their discovery, Fas and its ligand were quickly appreci-
ated to have a dual role in both cytotoxic functions and
autoregulatory cell death. For example, genetic abnor-
malities of Fas and its ligand lead to distorted lympho-
cyte homeostasis, leading to the autoimmune lympho-
proliferative syndrome (ALPS) (Lenardo et al., 1999).
Nevertheless, the molecular nature of autoregulatory
death in different T cell subsets were never fully workedout, and this is where the paper by Devadas et al. and
a related work (Sharma et al., 2006) make an important
contribution to our understanding of immune regulation.
In the simplest paradigm, naive CD4+ T helper cells
(Th0 cells) can respond to specific conditions of Ag stim-
ulation by differentiating into specialized Th1 or Th2 off-
spring that promote different types of immune responses
(see London et al., 1998 and Farrar et al., 2002 for a full
delineation of their molecular and functional differ-
ences). Interestingly, although both Th1 and Th2 cells
undergo autoregulatory cell death, Th1 cells are very
sensitive to killing through Fas but Th2 cells are relatively
insensitive (Oberg et al., 1997). This puzzling observation
has lingered for nearly a decade without a good explana-
tion for how Th2 cells control themselves. Now, Devadas
et al. (2006) address this conundrum by demonstrating
that granzyme B (GrB), previously implicated in CD8+
T cell and NK cytotoxicity, is crucial for autoregulatory
cell death in Th2 cells. Thus, evolution appears to have
redeployed the same two cytolytic mechanisms used
in immune defense to autoregulate the different subsets
of cells by promoting their own suicide under appropri-
ate conditions.
Devadas et al. make a clear case for the importance of
GrB in Th2 cell death (Figure 1). They find that the GrB-
specific inhibitor zAAD-cmk and a cathepsin C inhibitor
(which prevents the processing of GrB) efficiently pro-
tect Th2 cells from death, whereas caspase inhibitors
have no effect. In contrast, autoregulatory death of Th1
cells can only be blocked by caspase inhibitors, which
inhibit key proteolytic events in apoptosis. Devadas
et al. provide further insights into the regulation of GrB,
which is normally expressed at low amounts in naive
CD4+ T cells. They show that T cell receptor (TCR) stim-
ulation upregulates GrB in both Th1 and Th2 cells; how-
ever, it is differentially controlled in the two subsets. In
Th1 cells, the induced GrB remains sequestered in the
lysosomes during cell-death induction as indicated by
colocalization with the lysosome-associated membrane
protein LAMP-1. In contrast, TCR engagement in Th2
cells leads to the internal release of GrB from cellular
granules into the cytosol and nucleus with toxic conse-
quences for the cell. Release of cytotoxic granules is
ordinarily vectorial and external when a cytolytic T cell
encounters a target cell. The killing proteins are released
toward the target cell, and the T cell itself is spared.
However, the direct GrB release into the cytoplasm en-
sures the suicidal demise of Th2 cells. The authors also
show that differentially expressed protein inhibitors
guide the helper T cells into the two distinct pathways.
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T Cell-Receptor-Induced Cell Death in CD4+
T Helpers
Naive CD4+ T helper (Th0) cells differentiate
into Th1 or Th2 cells under specific differenti-
ating conditions after antigen stimulation.
These Th1 and Th2 cells proliferate and carry
out effector functions by producing different
cytokines that control immune responses.
The serine protease inhibitor (SPI)-6, a protein
that maintains lysosome integrity, and death
receptor CD95 are strongly induced in Th1
cells; whereas, cFLIP, a cellular caspase-8
inhibitory protein and SPI-2A, an endogenous
protein that inhibits caspase-3 and -9 activi-
ties, are specifically up regulated in Th2 cells.
These molecules allow Th1 and Th2 cells to
undergo CD95- or caspase-dependent and
granzyme B (GrB)-dependent homeostatic
death, respectively. T cell-receptor-induced
cell death (TICD) reduces the number of dif-
ferentiated T helper cells and, in turn, estab-
lishes homeostasis in the immune system.The serine protease inhibitor (SPI)-6 is specifically in-
duced in Th1 cells to inhibit GrB, and SPI-2A is increased
in Th2 cells to effectively block caspase-3 and -9. The
Sharma et al. study complements the Devadas et al.
findings by revealing that external agents such as vaso-
active intestinal peptide (VIP) can potently block GrB
and promote Th2 cell survival. VIP is strongly expressed
in the gut and therefore could prolong Th2-driven im-
mune responses by preventing the death of Th2 cells.
The important concept to emerge from these studies
is that the survival of Th1 and Th2 cells is differentially
controlled. Thus, a bias toward Th1 or Th2 cell promi-
nence in immune responses can result from molecularly
distinct modes of autoregulatory cell death in addition
to what takes place during activation. Although not yet
fully explored, this type of control might also be ex-
pected to influence the kinetics and persistence of spe-
cific immune responses. It will be interesting to see
whether the newly described GrB-dependent pathway
is genetically altered in the growing number of ‘‘Type
III’’ cases of ALPS in which no abnormalities in the
CD95 pathway are found and a bias toward Th2 immune
responses is evident (Lenardo et al., 1999). Finally,
differential regulation in biological responses always
raises hopes that specific pharmaceutical intervention
is possible. For example, Th2 cells have been shown
to have anti-inflammatory properties in certain con-
texts, and agents such as VIP may guide T cellresponses to a beneficial outcome in inflammatory or
autoimmune diseases. Although not necessarily simple
to exploit medically, these recent discoveries may be
a harbinger of interesting things to come in cell-death
and immune regulation.
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